276 related articles for article (PubMed ID: 28346423)
1. MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.
Otsubo K; Goto H; Nishio M; Kawamura K; Yanagi S; Nishie W; Sasaki T; Maehama T; Nishina H; Mimori K; Nakano T; Shimizu H; Mak TW; Nakao K; Nakanishi Y; Suzuki A
Oncogene; 2017 Jul; 36(29):4201-4211. PubMed ID: 28346423
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
[TBL] [Abstract][Full Text] [Related]
3. Loss of
Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
Development; 2018 Mar; 145(6):. PubMed ID: 29511023
[TBL] [Abstract][Full Text] [Related]
4. Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.
Nishio M; Hamada K; Kawahara K; Sasaki M; Noguchi F; Chiba S; Mizuno K; Suzuki SO; Dong Y; Tokuda M; Morikawa T; Hikasa H; Eggenschwiler J; Yabuta N; Nojima H; Nakagawa K; Hata Y; Nishina H; Mimori K; Mori M; Sasaki T; Mak TW; Nakano T; Itami S; Suzuki A
J Clin Invest; 2012 Dec; 122(12):4505-18. PubMed ID: 23143302
[TBL] [Abstract][Full Text] [Related]
5. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.
Yanagi S; Kishimoto H; Kawahara K; Sasaki T; Sasaki M; Nishio M; Yajima N; Hamada K; Horie Y; Kubo H; Whitsett JA; Mak TW; Nakano T; Nakazato M; Suzuki A
J Clin Invest; 2007 Oct; 117(10):2929-40. PubMed ID: 17909629
[TBL] [Abstract][Full Text] [Related]
6. Loss of Mob1a/b impairs the differentiation of mouse embryonic stem cells into the three germ layer lineages.
Bae JS; Kim SM; Jeon Y; Sim J; Jang JY; Son J; Hong W; Park MK; Lee H
Exp Mol Med; 2019 Nov; 51(11):1-12. PubMed ID: 31723125
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
8. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
Lin C; Yao E; Chuang PT
Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
[TBL] [Abstract][Full Text] [Related]
9. TAZ inhibits acinar cell differentiation but promotes immature ductal cell proliferation in adult mouse salivary glands.
Miyachi Y; Nishio M; Otani J; Matsumoto S; Kikuchi A; Mak TW; Maehama T; Suzuki A
Genes Cells; 2021 Sep; 26(9):714-726. PubMed ID: 34142411
[TBL] [Abstract][Full Text] [Related]
10. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
Nagashima S; Bao Y; Hata Y
Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
[TBL] [Abstract][Full Text] [Related]
11. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
12. Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ.
Guo L; Cai T; Chen K; Wang R; Wang J; Cui C; Yuan J; Zhang K; Liu Z; Deng Y; Xiao G; Wu C
J Cell Biol; 2018 Apr; 217(4):1431-1451. PubMed ID: 29496737
[TBL] [Abstract][Full Text] [Related]
13. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth.
Strnadel J; Choi S; Fujimura K; Wang H; Zhang W; Wyse M; Wright T; Gross E; Peinado C; Park HW; Bui J; Kelber J; Bouvet M; Guan KL; Klemke RL
Cancer Res; 2017 Apr; 77(8):1997-2007. PubMed ID: 28381547
[TBL] [Abstract][Full Text] [Related]
14. The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
Cancer Lett; 2018 Jun; 423():36-46. PubMed ID: 29452146
[TBL] [Abstract][Full Text] [Related]
15. MOB1 regulates thymocyte egress and T-cell survival in mice in a YAP1-independent manner.
Kato W; Nishio M; To Y; Togashi H; Mak TW; Takada H; Ohga S; Maehama T; Suzuki A
Genes Cells; 2019 Jul; 24(7):485-495. PubMed ID: 31125466
[TBL] [Abstract][Full Text] [Related]
16. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
17. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
18. Metabolic control of YAP and TAZ by the mevalonate pathway.
Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G
Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687
[TBL] [Abstract][Full Text] [Related]
19. The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation.
Fallah S; Beaulieu JF
Cells; 2020 Aug; 9(8):. PubMed ID: 32823612
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
